Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 31

Results For "President"

2636 News Found

Teva launches Home Ground platform to tackle isolation in schizophrenia care
Digitisation | April 16, 2026

Teva launches Home Ground platform to tackle isolation in schizophrenia care

The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping


Erin Lichy teams with Allergan Aesthetics to open up about breast augmentation
News | April 16, 2026

Erin Lichy teams with Allergan Aesthetics to open up about breast augmentation

Through the partnership, she plans to share her experience—from consultation through recovery—across her social media platforms


India Pharma 2026 concludes with strong call for funding, infrastructure and speed to power innovation
Policy | April 15, 2026

India Pharma 2026 concludes with strong call for funding, infrastructure and speed to power innovation

The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions


Vetter ramps up global clinical manufacturing push with major US & Europe expansion
News | April 15, 2026

Vetter ramps up global clinical manufacturing push with major US & Europe expansion

The goal is to better support drug developers as programs move from laboratory research into clinical trials


Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations
R&D | April 15, 2026

Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations

The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations


FDA grants priority review to Daiichi Sankyo & Merck’s lung cancer drug application
Drug Approval | April 15, 2026

FDA grants priority review to Daiichi Sankyo & Merck’s lung cancer drug application

The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck


DCDC Kidney Care launches Academy of Healthcare to build India’s dialysis workforce
Hospitals | April 15, 2026

DCDC Kidney Care launches Academy of Healthcare to build India’s dialysis workforce

New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education


Microbot Medical begins full US market release of LIBERTY endovascular robotic system
Medical Device | April 15, 2026

Microbot Medical begins full US market release of LIBERTY endovascular robotic system

Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology


Regeneron and Telix strike major radiopharma pact in push into next-gen cancer therapies
R&D | April 15, 2026

Regeneron and Telix strike major radiopharma pact in push into next-gen cancer therapies

The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio